HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tai W Wong Selected Research

BMS-690514

12/2013Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth.
6/2011Antitumor and antiangiogenic activities of BMS-690514, an inhibitor of human EGF and VEGF receptor kinase families.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tai W Wong Research Topics

Disease

10Neoplasms (Cancer)
12/2013 - 05/2005
2Colorectal Neoplasms (Colorectal Cancer)
02/2015 - 08/2007
2Ovarian Neoplasms (Ovarian Cancer)
12/2013 - 09/2008
2Carcinogenesis
12/2013 - 05/2005
2Breast Neoplasms (Breast Cancer)
09/2008 - 03/2007
2Carcinoma (Carcinomatosis)
03/2008 - 08/2005
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2007
1Philadelphia Chromosome
03/2007
1Lung Neoplasms (Lung Cancer)
03/2007
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2007
1Colonic Neoplasms (Colon Cancer)
08/2005
1Adenocarcinoma
05/2005

Drug/Important Bio-Agent (IBA)

5Phosphotransferases (Kinase)IBA
06/2011 - 05/2005
3ErbB Receptors (EGF Receptor)IBA
01/2011 - 08/2005
3Cetuximab (Erbitux)FDA Link
01/2011 - 08/2005
2Biomarkers (Surrogate Marker)IBA
02/2015 - 08/2005
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2013 - 01/2011
2BMS-690514IBA
12/2013 - 06/2011
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2011 - 05/2005
2(4- ((1- (3- fluorophenyl)methyl)- 1H- indazol- 5- ylamino)- 5- methylpyrrolo(2,1- f)(1,2,4)triazin- 6- yl)carbamic acid 3-morpholinylmethyl esterIBA
09/2008 - 10/2006
2Insulin-Like Growth Factor I (IGF-1)IBA
09/2008 - 05/2005
1BMS 754807IBA
02/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2013
1cediranib (AZD2171)IBA
12/2013
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2013
1Proteins (Proteins, Gene)FDA Link
11/2011
1Small Interfering RNA (siRNA)IBA
11/2011
1Protein Isoforms (Isoforms)IBA
11/2011
1Fatty Acids (Saturated Fatty Acids)IBA
11/2011
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2011
1LipidsIBA
11/2011
1Stearoyl-CoA DesaturaseIBA
11/2011
1matrigelIBA
06/2011
1AntibodiesIBA
01/2011
1Biological ProductsIBA
01/2011
1Epidermal Growth Factor (EGF)IBA
01/2011
1nimotuzumabIBA
01/2011
1Fibronectins (Fibronectin)IBA
01/2011
1Panitumumab (Vectibix)FDA Link
01/2011
1Insulin ReceptorIBA
09/2008
1BMS 536924IBA
09/2008
1BMS-554417IBA
09/2008
1malonamideIBA
03/2008
1AmidesIBA
03/2008
1LigandsIBA
08/2007
1EpiregulinIBA
08/2007
1AmphiregulinIBA
08/2007
1Growth Factor ReceptorsIBA
08/2007
1Estrogen ReceptorsIBA
03/2007
1Progesterone Receptors (Progesterone Receptor)IBA
03/2007
1Dasatinib (BMS 354825)FDA Link
03/2007
1tyrosine receptor (receptor, tyrosine)IBA
06/2006
1Immunoglobulin G (IgG)IBA
08/2005
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2005
1Monoclonal AntibodiesIBA
08/2005
1Pharmaceutical PreparationsIBA
08/2005
1AS 8IBA
05/2005

Therapy/Procedure

5Therapeutics
11/2011 - 06/2006